← Leaderboards
Karin E. Bornfeldt
University Of Washington
$36,322,585
Attributed
$39,918,926
Total exposure
23
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$69,050,196 · 25
By mechanism
P01$38,305,858 · 9
R01$14,266,534 · 8
R35$6,150,289 · 1
T32$3,500,214 · 1
P30$2,677,184 · 3
U01$2,123,110 · 1
Top collaborators
- Jay W Heinecke5 shared
- Petter Bjornstad2 shared
- Tomas Vaisar2 shared
Most similar at University Of Washington
Same institution · by research overlap
- Alan Chait$20,398,633
- Jay W Heinecke$34,087,651
- Jan Christian Lood$4,492,233
- John J Albers$2,283,792
- Renee C Leboeuf$13,817,725
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisDiabetes MellitusMacrophageCardiovascular DiseasesLesionArterial Fatty StreakProgramsDiabeticTriglyceridesCellsCardiovascular Disorder RiskMouse ModelResearch PersonnelCardiovascular SystemInsulin-Dependent Diabetes MellitusLipoproteinsObesityPathway InteractionsPlasmaInflammatoryPreventDiabetic MouseProductionAtherogenesis
Grant awards (112)
Triglycerides, Diabetes and Cardiovascular Disease$2,622,487
P01 · FY2025 · HL · contact PI
Identifying new strategies for prevention of cardiovascular complications of diabetes$1,053,013
R35 · FY2025 · HL · contact PI
Immunometabolism and the Cardio-Renal Axis in T1D-associated Atherosclerosis: Insights from the CaRe T1D Biobank$1,042,430
U01 · FY2025 · DK · contact PI
Project 1. Type 2 diabetes, APOC3 and cardiovascular disease$633,102
P01 · FY2025 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$364,337
T32 · FY2025 · HL · contact PI
CRISPR, VECTOR AND TRANSGENIC MOUSE CORE$193,808
P30 · FY2025 · DK · contact PI
Administrative Core$185,711
P01 · FY2025 · HL · contact PI
Triglycerides, Diabetes and Cardiovascular Disease$2,453,240
P01 · FY2024 · HL · contact PI
Immunometabolism and the Cardio-Renal Axis in T1D-associated Atherosclerosis: Insights from the CaRe T1D Biobank$1,080,680
U01 · FY2024 · DK · contact PI
Identifying new strategies for prevention of cardiovascular complications of diabetes$1,002,374
R35 · FY2024 · HL · contact PI
Project 1. Diabetes, triglyceride-rich lipoproteins, and advanced atherosclerosis$501,372
P01 · FY2024 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$367,531
T32 · FY2024 · HL · contact PI
CRISPR, VECTOR AND TRANSGENIC MOUSE CORE$193,809
P30 · FY2024 · DK · contact PI
Administrative Core$188,411
P01 · FY2024 · HL · contact PI
Triglycerides, Diabetes and Cardiovascular Disease$2,390,187
P01 · FY2023 · HL · contact PI
Identifying new strategies for prevention of cardiovascular complications of diabetes$1,022,830
R35 · FY2023 · HL · contact PI
Structural basis for cardioprotective HDL$691,232
R01 · FY2023 · HL
Project 1. Diabetes, triglyceride-rich lipoproteins, and advanced atherosclerosis$419,043
P01 · FY2023 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$353,205
T32 · FY2023 · HL · contact PI
CRISPR, VECTOR AND TRANSGENIC MOUSE CORE$193,808
P30 · FY2023 · DK · contact PI
Administrative Core$191,933
P01 · FY2023 · HL · contact PI
Triglycerides, Diabetes and Cardiovascular Disease$2,360,354
P01 · FY2022 · HL · contact PI
Identifying new strategies for prevention of cardiovascular complications of diabetes$1,016,402
R35 · FY2022 · HL · contact PI
Structural basis for cardioprotective HDL$691,232
R01 · FY2022 · HL
Project 1. Diabetes, triglyceride-rich lipoproteins, and advanced atherosclerosis$404,744
P01 · FY2022 · HL · contact PI
Vector and Transgenic Mouse Core$248,333
P30 · FY2022 · DK · contact PI
Administrative Core$190,916
P01 · FY2022 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$187,336
T32 · FY2022 · HL · contact PI
Triglycerides, Diabetes and Cardiovascular Disease$2,342,163
P01 · FY2021 · HL · contact PI
Identifying new strategies for prevention of cardiovascular complications of diabetes$1,017,915
R35 · FY2021 · HL · contact PI
Structural basis for cardioprotective HDL$691,232
R01 · FY2021 · HL
Project 1. Diabetes, triglyceride-rich lipoproteins, and advanced atherosclerosis$387,419
P01 · FY2021 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$301,938
T32 · FY2021 · HL · contact PI
Vector and Transgenic Mouse Core$236,302
P30 · FY2021 · DK · contact PI
Administrative Core$190,856
P01 · FY2021 · HL · contact PI
Triglycerides, Diabetes and Cardiovascular Disease$2,409,622
P01 · FY2020 · HL · contact PI
Identifying new strategies for prevention of cardiovascular complications of diabetes$1,037,755
R35 · FY2020 · HL · contact PI
Structural basis for cardioprotective HDL$688,354
R01 · FY2020 · HL
Project 1. Diabetes, triglyceride-rich lipoproteins, and advanced atherosclerosis$388,218
P01 · FY2020 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$289,665
T32 · FY2020 · HL · contact PI
Vector and Transgenic Mouse Core$236,302
P30 · FY2020 · DK · contact PI
Administrative Core$195,486
P01 · FY2020 · HL · contact PI
Cardiovascular Disease and Diabetes Program Project$2,406,329
P01 · FY2019 · HL · contact PI
Project 4: Diabetes-induced Myeloid Cell Activation, HDL and Atherosclerosis$469,160
P01 · FY2019 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$284,736
T32 · FY2019 · HL · contact PI
Vector and Transgenic Mouse Core$235,908
P30 · FY2019 · DK · contact PI
Probing human leukocytes to target inflammatory macrophage proliferation in chronic inflammation$194,375
R21 · FY2019 · AI · contact PI
Administrative Core$177,390
P01 · FY2019 · HL · contact PI
Cardiovascular Disease and Diabetes Program Project$2,466,809
P01 · FY2018 · HL · contact PI
Proteolytic control of local inflammatory macrophage proliferation$494,162
R01 · FY2018 · HL · contact PI
Project 4: Diabetes-induced Myeloid Cell Activation, HDL and Atherosclerosis$481,310
P01 · FY2018 · HL · contact PI
Obesity and Arterial Metabolism$435,000
R01 · FY2018 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$292,326
T32 · FY2018 · HL · contact PI
Vector and Transgenic Mouse Core$235,629
P30 · FY2018 · DK · contact PI
Probing human leukocytes to target inflammatory macrophage proliferation in chronic inflammation$232,813
R21 · FY2018 · AI · contact PI
Administrative Core$181,982
P01 · FY2018 · HL · contact PI
Cardiovascular Disease and Diabetes Program Project$2,466,716
P01 · FY2017 · HL · contact PI
Proteolytic control of local inflammatory macrophage proliferation$494,162
R01 · FY2017 · HL · contact PI
Project 4: Diabetes-induced Myeloid Cell Activation, HDL and Atherosclerosis$481,288
P01 · FY2017 · HL · contact PI
Obesity and Arterial Metabolism$435,000
R01 · FY2017 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$215,260
T32 · FY2017 · HL · contact PI
Core A: Viral Vector and Transgenic Mouse Core$183,108
P30 · FY2017 · DK · contact PI
Administrative Core$181,974
P01 · FY2017 · HL · contact PI
Cardiovascular Disease and Diabetes Program Project$176,000
P01 · FY2017 · HL · contact PI
Cardiovascular Disease and Diabetes Program Project$41,853
P01 · FY2017 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$2,986
T32 · FY2017 · HL · contact PI
Cardiovascular Disease and Diabetes Program Project$2,367,774
P01 · FY2016 · HL · contact PI
Project 4: Diabetes-induced Myeloid Cell Activation, HDL and Atherosclerosis$461,028
P01 · FY2016 · HL · contact PI
Obesity and Arterial Metabolism$435,000
R01 · FY2016 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$276,817
T32 · FY2016 · HL · contact PI
Core A: Viral Vector and Transgenic Mouse Core$183,106
P30 · FY2016 · DK · contact PI
Administrative Core$174,494
P01 · FY2016 · HL · contact PI
Cardiovascular Disease and Diabetes Program Project$2,401,515
P01 · FY2015 · HL · contact PI
APOC3, HDL Function and Cardiovascular Complications of T1DM$1,599,819
DP3 · FY2015 · DK · contact PI
Project 4: Diabetes-induced Myeloid Cell Activation, HDL and Atherosclerosis$476,269
P01 · FY2015 · HL · contact PI
ADAM-mediated Shedding in Endothelial Inflammatory Responses$440,843
R01 · FY2015 · HL · contact PI
Obesity and Arterial Metabolism$435,000
R01 · FY2015 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$250,880
T32 · FY2015 · HL · contact PI
Core A: Viral Vector and Transgenic Mouse Core$183,048
P30 · FY2015 · DK · contact PI
Administrative Core$174,494
P01 · FY2015 · HL · contact PI
Cell Signaling: Macrovascular Complications of Diabetes$426,300
R01 · FY2014 · HL · contact PI
Nutrition, Obesity and Atherosclerosis Training Program$313,197
T32 · FY2014 · HL · contact PI
Core A: Viral Vector and Transgenic Mouse Core$183,146
P30 · FY2014 · DK · contact PI
Cell Signaling: Macrovascular Complications of Diabetes$414,120
R01 · FY2013 · HL · contact PI
S100A9 and S100A8 in Diabetes and Atherosclerosis$391,129
R01 · FY2013 · HL · contact PI
Core A: Viral Vector and Transgenic Mouse Core$170,877
P30 · FY2013 · DK · contact PI
Pathobiology of Macrovascular Disease in Diabetes$2,226,221
P01 · FY2012 · HL · contact PI
Cell Signaling: Macrovascular Complications of Diabetes$432,500
R01 · FY2012 · HL · contact PI
S100A9 and S100A8 in Diabetes and Atherosclerosis$410,850
R01 · FY2012 · HL · contact PI
Acyl-CoAs, Inflammation, and Atherogenesis in Diabetes$407,600
P01 · FY2012 · HL · contact PI
Cell Signaling: Macrovascular Complications of Diabetes$430,000
R01 · FY2011 · HL · contact PI
S100A9 and S100A8 in Diabetes and Atherosclerosis$415,000
R01 · FY2011 · HL · contact PI
Acyl-CoAs, Inflammation, and Atherogenesis in Diabetes$407,598
P01 · FY2011 · HL · contact PI
S100A9 and S100A8 in Diabetes and Atherosclerosis$415,000
R01 · FY2010 · HL · contact PI
Acyl-CoAs, Inflammation, and Atherogenesis in Diabetes$407,598
P01 · FY2010 · HL · contact PI
Acyl-CoAs, Inflammation, and Atherogenesis in Diabetes$407,598
P01 · FY2009 · HL · contact PI
Cell Signaling: Macrovascular Complications of Diabetes$378,690
R01 · FY2009 · HL · contact PI
Acyl-CoAs, Inflammation, and Atherogenesis in Diabetes$407,594
P01 · FY2008 · HL · contact PI
Cell Signaling: Macrovascular Complications of Diabetes$378,690
R01 · FY2008 · HL · contact PI
Acyl-CoAs and Lesion Initiation in Diabetes$166,443
R01 · FY2008 · HL · contact PI
Acyl-CoAs and Lesion Initiation in Diabetes$384,387
R01 · FY2007 · HL · contact PI
Cell Signaling: Macrovascular Complications of Diabetes$378,387
R01 · FY2007 · HL · contact PI
LONG-CHAIN ACYL-COA SYNTHETASES IN VASCULAR CELLS$359,360
R01 · FY2007 · HL · contact PI
Cell Signaling: Macrovascular Complications of Diabetes$388,750
R01 · FY2006 · HL · contact PI
LONG-CHAIN ACYL-COA SYNTHETASES IN VASCULAR CELLS$370,094
R01 · FY2006 · HL · contact PI
LONG-CHAIN ACYL-COA SYNTHETASES IN VASCULAR CELLS$379,000
R01 · FY2005 · HL
Cell Signaling: Macrovascular Complications of Diabetes$303,200
R01 · FY2005 · HL
LONG-CHAIN ACYL-COA SYNTHETASES IN VASCULAR CELLS$379,000
R01 · FY2004 · HL
Cell Signaling: Macrovascular Complications of Diabetes$303,200
R01 · FY2004 · HL
Cell Signaling: Macrovascular Complications of Diabetes$303,200
R01 · FY2003 · HL
Cell Signaling: Macrovascular Complications of Diabetes$303,667
R01 · FY2002 · HL
HYPERGLYCEMIA, PROTEIN KINASES AND SMOOTH MUSCLE GROWTH$224,350
R01 · FY2000 · HL